HANKIL LEE Associate Professor
Pharmaceutical Sciences / College of Medicine / Industrial Pharmaceutical Science / Division of Pharmacy
- hankil@ewha.ac.kr
- Department Chair, Interdisciplinary Program of Applied Science and Technology for Skin Health and Aesthetics/Department Chair, Interdisciplinary Pharmacy
- Pharmaceutical Science Building B #411
- 02-3277-4504
- Research Interests
- Health Technology Assessment, Economic Evaluation, Regulatory Science, Outcomes Research, Pharmacoepidemiology
Research Record
- Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies Including Second-Line Therapy Korean Journal of Helicobacter Upper Gastrointestinal Research, 2026, v.26 no.2, 189-195
- Nationwide insights on early childhood neurodevelopment during a global health crisis: evidence from COVID-19 in South Korea Journal of Global Health, 2026, v.16, 4026
- Prostate cancer in Korea: Nationwide trends in prevalence and medication use during 2011–2021 Cancer Epidemiology, 2026, v.101, 102987
- Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD KIDNEY INTERNATIONAL REPORTS, 2026, v.11 no.6, 106524
- Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis Journal of Gastroenterology and Hepatology (Australia), 2026, v.41 no.1, 28-40
- 유전자치료제의 급여 및 재정 지불 모형에 대한 국제 비교 및 정책적 함의 약 학 회 지, 2026, v.70 no.3, 179-192
- Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis HELICOBACTER, 2025, v.30 no.5, e70081
- Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6, e70063
- Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs Expert Opinion on Drug Safety, 2025, v.24 no.8, 899-907
- Risk of Alzheimer’s disease and Parkinson’s disease following androgen deprivation therapy in a real world nationwide cohort Scientific Reports, 2025, v.15 no.1, 23490
- Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting Journal of Urologic Oncology, 2025, v.23 no.3, 236-246
- [학술지논문] Comparative risk of pneumonia and acute exacerbation between P-CAB and PPI use in patients with COPD and GERD NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2026, v.36 no.53 , 0-0
- [학술지논문] Economic Evaluation of Empirical and Tailored Helicobacter pylori Eradication Strategies Including Second-Line Therapy Korean Journal of Helicobacter Upper Gastrointestinal Research, 2026, v.26 no.2 , 189-195
- [학술지논문] Economic burden of treatment resistant depression in Korea: a 28-day health-state-specific cost analysis CURRENT MEDICAL RESEARCH AND OPINION, 2026, v.42 no.4 , 739-749
- [학술지논문] Optimizing hepatitis C micro-elimination in forensic psychiatric settings: Cost-effectiveness of screening strategies in Korea JOURNAL OF INFECTION AND PUBLIC HEALTH, 2026, v.19 no.9 , 0-0
- [학술지논문] Prostate cancer in Korea: Nationwide trends in prevalence and medication use during 2011-2021 CANCER EPIDEMIOLOGY, 2026, v.101 no.0 , 0-0
- [학술지논문] Renal Outcomes With Potassium-Competitive Acid Blockers Versus Proton Pump Inhibitors in CKD Kidney International Reports, 2026, v.11 no.6 , 106524-106524
- [학술지논문] Risk of Liver and Kidney Adverse Events After Androgen Deprivation Therapy in Prostate Cancer: A Population-Based Retrospective Cohort Study Journal of Urologic Oncology, 2026, v.24 no.1 , 21-33
- [학술지논문] Safety of Potassium-Competitive Acid Blockers Compared With Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease and Peptic Ulcer Disease: A Systematic Review and Meta-Analysis JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2026, v.41 no.1 , 28-40
- [학술지논문] 유전자치료제의 급여 및 재정 지불 모형에 대한 국제 비교 및 정책적 함의 약 학 회 지, 2026, v.70 no.3 , 179-192
- [학술지논문] A multicenter micro-costing analysis of flexible cystoscopic procedures in Korea INVESTIGATIVE AND CLINICAL UROLOGY, 2025, v.66 no.1 , 87-96
- [학술지논문] Analysis of Medication Adherence and Influencing Factors in Patients With Treatment-Resistant Hypertension in South Korea: A Nationwide Retrospective Cohort Study 보건의료기술평가, 2025, v.13 no.2 , 105-114
- [학술지논문] Assessing the Risk of Cognitive Impairment associated with Androgen Receptor Targeting Agent Use in Metastatic Prostate Cancer: A Systematic Review of Real-world Data 약 학 회 지, 2025, v.69 no.2 , 125-134
- [학술지논문] COVID-19 infection in patients with end-stage kidney disease undergoing renal replacement therapies in Korea KIDNEY RESEARCH AND CLINICAL PRACTICE, 2025, v.44 no.3 , 522-533
- [학술지논문] Clinician guidance in digital therapeutics for panic disorder: Meta-analytic dissection and implications for regulatory framing and scalable deployment JOURNAL OF ANXIETY DISORDERS, 2025, v.115 no.- , 103074-103074
- [학술지논문] Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis HELICOBACTER, 2025, v.30 no.5 , 70081-70081
- [학술지논문] Economic Evaluation of Rituximab Versus Corticosteroid-Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea NEPHROLOGY, 2025, v.30 no.6 , 70063-70063
- [학술지논문] Incidence and risk of drug-induced interstitial lung disease associated with anti-neoplastic drugs EXPERT OPINION ON DRUG SAFETY, 2025, v.24 no.8 , 899-907
- [학술지논문] Insignificant difference in medication adherence to dyslipidemia drugs between visually impaired and non-disabled people in South Korea: A nationwide cohort study using claims records PLOS ONE, 2025, v.20 no.1 , 0-0
- [학술지논문] Oral Branched-Chain Amino Acids as a Cost-Effective Option for Managing Hepatic Encephalopathy YONSEI MEDICAL JOURNAL, 2025, v.66 no.11 , 713-721
- [학술지논문] Prescription trends of gastric acid suppressants and association with potential adverse events in Korea: a real-world cross-sectional study Therapeutic Advances in Gastroenterology, 2025, v.18 no.0 , 0-0
- [학술지논문] Risk of Alzheimer's disease and Parkinson's disease following androgen deprivation therapy in a real world nationwide cohort SCIENTIFIC REPORTS, 2025, v.15 no.1 , 23490-23490
- [학술지논문] Self-testing strategy to eliminate hepatitis C as per World Health Organization's goal: Analysis of disease burden and cost-effectiveness CLINICAL AND MOLECULAR HEPATOLOGY, 2025, v.31 no.1 , 166-178
- [학술지논문] Treatment Patterns and Survival Outcomes in Korean Patients With Metastatic Hormone-Sensitive Prostate Cancer in a Real-World Setting Journal of Urologic Oncology, 2025, v.23 no.3 , 236-246
- [학술지논문] Regional Disparities and Related Factors in Blood Pressure and Blood Sugar Awareness in Suwon City: Analysis Using Community Health Survey Data 보건의료기술평가, 2025, v.13 no.1 , 22-30
- [학술지논문] Cost-effectiveness Analysis of COMT-inhibitors as Adjuvant Treatments to Levodopa in Patients with Advanced Parkinson's Disease CLINICAL THERAPEUTICS, 2024, v.46 no.9 , 670-676
- [학술지논문] Determinants of immune checkpoint inhibitor use and factors linked to neurological adverse events in Korean lung cancer FUTURE ONCOLOGY, 2024, v.20 no.39 , 3245-3256
- [학술지논문] Expert survey on real-world data utilization and real-world evidence generation for regulatory decision-making in drug lifecycle in Korea CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, v.17 no.4 , 13801-13801
- [학술지논문] Kidney replacement therapy trends in end-stage kidney disease patients in South Korea during the COVID-19 pandemic KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, v.39 no.6 , 967-978
- [학술지논문] Recent updates on treatment patterns in patients with treated attention-deficit/hyperactivity disorders from a nationwide real-world database in South Korea INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2024, v.39 no.4 , 240-249
- [학술지논문] Unveiling the chasm of economic burden from metastatic prostate cancer through a nationwide retrospective cohort study CURRENT MEDICAL RESEARCH AND OPINION, 2024, v.40 no.12 , 2155-2162
- [학술발표] Clinical and Economic Characteristics of EGFR-mutated NSCLC Patients Treated with TKIs in South Korea: A Retrospective Cross-Sectional Analysis ISPOR Europe, 스코트랜드, Glasgow, 2025-11-11 Value in Health, 2025
- [학술발표] Sex Differences in Characteristics and Treatment Patterns of Patients With Sleep Disorders in South Korea ISPOR Europe, 스코트랜드, Glasgow, 2025-11-12 Value in Health, 2025
Courses
-
2026-2nd
-
Advanced Pharmacy Practice and Research I
- Subject No 37154Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅱ
- Subject No 37155Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Advanced Pharmacy Practice and Research Ⅲ
- Subject No 37156Class No 02
- 6Year ( 4Credit , 200Hour)
- Major Requisite
-
Honors Research Ⅰ
- Subject No 38982Class No 01
- 4Year ( 1.5Credit
-
Pharmacy Administration
- Subject No 38990Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Fri 4~4 (PHM-A404)
- Major Requisite
-
Pharmaceutical Jurisprudence
- Subject No 39002Class No 01
- 5Year ( 1.5Credit , 1.5Hour) Mon 3~3 (PHM-A400)
- Major Requisite,Language Changed
-
Honors Research Ⅱ
- Subject No 39015Class No 01
- 5Year ( 1.5Credit
-
Honors Research Ⅰ
- Subject No 39087Class No 01
- 4Year ( 1.5Credit
-
Pharmacy Administration
- Subject No 39095Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Fri 3~3 (POSCO359)
- Major Requisite
-
Strategic Management & Healthcare
- Subject No 39249Class No 01
- 4Year ( 3Credit , 3Hour) Tue 5~6 (POSCO551)
- Major Requisite
-
Project Analysis Ⅱ
- Subject No G16666Class No 01
- Year ( 3Credit , 3Hour) Fri 8~9 (PHM-)
- Professor Changed
-
Methods in Economic Evaluation in Pharmaceuticals Ⅰ
- Subject No G16816Class No 01
- Year ( 3Credit , 3Hour) Thu 5~6 (PHM-A204)
- Professor Determined
-
Pharmacoepidemiology
- Subject No G17173Class No 01
- Year ( 3Credit , 3Hour) Tue 8~9 (PHM-A204)
-
Statistical Methods in Applied Research Ⅱ
- Subject No G18930Class No 01
- Year ( 3Credit , 3Hour) Mon 8~9 (PHM-A204)
-
-
2026-1st
-
Industrial Pharmacy & Administrative Pharmacy Practice
- Subject No 37153Class No 02
- 6Year ( 2.5Credit , 160Hour)
- Major Requisite
-
Pharmaceutical Statistics
- Subject No 38922Class No 01
- 1Year ( 1.5Credit , 1.5Hour) Wed 3~3 (PHM-A404)
- Major Requisite
-
Pharmacists and Society 강의 계획서 상세보기
- Subject No 38933Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
-
Honors Research Ⅰ
- Subject No 38982Class No 01
- 4Year ( 1.5Credit
-
Pharmaco Epdemiology
- Subject No 38985Class No 01
- 5Year ( 1.5Credit , 1.5Hour) Wed 4~4 (POSCO261)
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39014Class No 01
- 5Year ( 3Credit , 4.5Hour) Tue 5~10 (PHM-A214)
- Major Requisite
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39014Class No 02
- 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
- Major Requisite
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39014Class No 03
- 5Year ( 3Credit , 4.5Hour) Wed 5~10 (PHM-A214)
- Major Requisite
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39014Class No 04
- 5Year ( 3Credit , 4.5Hour) Mon 5~10 (PHM-A214)
- Major Requisite
-
Honors Research Ⅱ
- Subject No 39015Class No 01
- 5Year ( 1.5Credit
-
Pharmaceutical Statistics
- Subject No 39026Class No 01
- 1Year ( 1.5Credit , 1.5Hour) Wed 5~5 (POSCO462)
- Major Requisite
-
Pharmacists and Society 강의 계획서 상세보기
- Subject No 39038Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 5~5 (PHM-A404)
-
Introduction to Pharmaceutical Research
- Subject No 39045Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A400)
-
Honors Research Ⅰ
- Subject No 39087Class No 01
- 4Year ( 1.5Credit
-
Pharmaco Epdemiology
- Subject No 39090Class No 01
- 5Year ( 1.5Credit , 1.5Hour) Wed 2~2 (POSCO551)
- Major Requisite
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39119Class No 01
- 5Year ( 3Credit , 4.5Hour) Tue 5~10 (PHM-A214)
- Major Requisite
-
Essential Pharmacy Practice Experiences 강의 계획서 상세보기
- Subject No 39119Class No 02
- 5Year ( 3Credit , 4.5Hour) Wed 5~10 (PHM-A214)
- Major Requisite
-
Honors Research Ⅱ
- Subject No 39120Class No 01
- 5Year ( 1.5Credit
-
Project Analysis Ⅰ
- Subject No G16659Class No 01
- Year ( 3Credit , 3Hour) Fri 7~8 (PHM-)
- Professor Determined
-
Principles of Pharmaceutical Economics and Policy
- Subject No G17175Class No 01
- Year ( 3Credit , 3Hour) Wed 6~7 (PHM-)
-
Methods in Economic Evaluation in Pharmaceuticals Ⅱ
- Subject No G17177Class No 01
- Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
-
Advanced Biotechnology Equipment and Experiments 강의 계획서 상세보기
- Subject No G18929Class No 01
- Year ( 3Credit , 3Hour) Tue 6~7 (PHM-A-400)
- Classroom Changed
-
Principles of Pharmaceutical Economics and Policy
- Subject No G18955Class No 01
- Year ( 3Credit , 3Hour) Wed 6~7 (PHM-)
-
Social Pharmacy
- Subject No AP530Class No 01
- Year ( 3Credit , 3Hour)
-
Social Pharmacy
- Subject No AR530Class No 01
- Year ( 3Credit , 3Hour)
-
-
2025-2nd
-
Honors research
- Subject No 37803Class No 01
- 4Year ( 1Credit , 1Hour)
-
Honors Research Ⅰ
- Subject No 38982Class No 01
- 4Year ( 1.5Credit
-
Pharmacy Administration 강의 계획서 상세보기
- Subject No 38990Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Fri 3~3 (PHM-A404)
- Major Requisite,Language Changed
-
Honors Research Ⅰ
- Subject No 39087Class No 01
- 4Year ( 1.5Credit
-
Pharmacy Administration 강의 계획서 상세보기
- Subject No 39095Class No 01
- 4Year ( 1.5Credit , 1.5Hour) Fri 4~4 (PHM-A404)
- Major Requisite,Language Changed
-
Strategic Management & Healthcare 강의 계획서 상세보기
- Subject No 39249Class No 01
- 4Year ( 3Credit , 3Hour) Tue 5~5 (PHM-A104) , Tue 6~6 (PHM-A104)
- Major Requisite,Language Changed
-
Methods in Economic Evaluation in Pharmaceuticals Ⅰ 강의 계획서 상세보기
- Subject No G16816Class No 01
- Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
-
Methods in Economic Evaluation 강의 계획서 상세보기
- Subject No G18086Class No 01
- Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
-
-
2025-1st
-
Pharmaceutical Statistics 강의 계획서 상세보기
- Subject No 38922Class No 01
- 1Year ( 1.5Credit , 1.5Hour) Wed 3~3 (PHM-A404)
- Major Requisite,Language Changed
-
Pharmacists and Society 강의 계획서 상세보기
- Subject No 38933Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Tue 4~4 (HAK251)
-
Pharmaceutical Statistics
- Subject No 39026Class No 01
- 1Year ( 1.5Credit , 1.5Hour) Wed 5~5 (POSCO462)
- Major Requisite,Language Changed
-
Pharmaceutical Statistics Computer Lab
- Subject No 39027Class No 01
- 1Year ( 1.5Credit , 1.5Hour) Wed 6~6 (POSCO159)
- Major Requisite,Language Changed
-
Pharmacists and Society 강의 계획서 상세보기
- Subject No 39038Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Tue 4~4 (HAK251)
-
Introduction to Pharmaceutical Research
- Subject No 39045Class No 01
- 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A104)
-
Pharmacoepidemiology 강의 계획서 상세보기
- Subject No G17173Class No 01
- Year ( 3Credit , 3Hour) Fri 8~9 (PHM-)
- Professor Determined
-
PharmacoEpidemiology 강의 계획서 상세보기
- Subject No G18085Class No 01
- Year ( 3Credit , 3Hour) Fri 8~9 (PHM-)
- Professor Determined
-
Academic Background
YONSEI UNIVERSITY 약학박사(약학과)
Ewha Womans University 약학석사(생명약학부)
Ewha Womans University 약학사(제약학과)
Work Experience
아주대 2021-03-01 ~ 2025-02-28
Department Chair, Interdisciplinary Pharmacy 2026-08-01 ~ 2028-07-31
